Proteomics-driven early cancer diagnostics company
Bertis to develop early detection technologies for cancer and major diseases and to provide diagnostic services. These research and development achievements at Bertis is the stepping stone of creating healthy and joyful humanity.
“BERTIS have developed NexQ Prot ™ a quantitative proteomics platform which enable high throughput discovery and validation of novel markers. This system increases the efficiency of development at 10X, overcoming current difficulties for proteomics based marker industrialization."
Site |
Badges |
|
BERTIS INC. (Yongin Laboratory)
13, Heungdeok 1-ro, Giheung-gu
Yongin-si, Gyeonggi-do, 16954
South Korea
|
|
|
BERTIS INC. (HQ)
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do, 13605
South Korea
|
|
|
BERTIS INC. (HQ)
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do, 13605
South Korea
|
|
|
BERTIS INC. (Seoul Office)
614, Nonhyeon-ro, Gangnam-gu
Seoul, Seoul, 06108
South Korea
|
|